Today's AI verdict on what's driving $MRLN, plus how loud the X conversation is and which way it's leaning.
What to watch: Next contract milestone — production-decision timing on the C-130J autonomy program is the natural follow-on catalyst. Plus the Aug 21 Q2 print: revenue needs to show first production-related dollars, not just R&D recognition.
On the calendar: 2026-08-21 — Q2 earnings
What the X crowd is saying right now — descriptive, summarised from the day’s posts.
Merlin announced it cleared CDR (Critical Design Review) with USSOCOM for the C-130J — bulls explicitly frame this as the dividing line between a 'science project' and a viable product, meaning the DoD has rigorously audited Merlin's design. The stock ran 20-35% on the news. Cowen recently initiated coverage at $11 PT, but their undiscounted Sum-of-DCF is $2,257M equating to $27.50/share before a 60% execution-risk haircut that bulls argue should now be reduced post-CDR. Bulls compare MRLN at 5.6x FY27 revenue to Anduril at ~13x and Saronic Series D, framing it as the next BRUN-style underrated defense bet. Management indicated no need to dilute shareholders to hit revenue ramp. The risk thread is sparse — mostly the typical venture-bet caveat.
Plain-English summary of the business — what they sell and how they make money.
Where Software - Application sits in its cycle right now — and what that implies for $MRLN.
Profitability, valuation, and the next earnings event — at a glance, with rule-of-thumb signals.
Volume, range, and moving-average position — the technical setup driving short-term moves.
Recent open-market buys and sells by officers and directors — flagged when multiple insiders cluster.
Latest headlines from major outlets, sourced and timestamped — context for whatever just moved.
Explore the broader themes this ticker is being talked about under.
Peers in the same group — one click to compare setups, fundamentals, and chatter.
